Ibuprofen arginate retains eNOS substrate activity and reverses endothelial dysfunction: implications for the COX-2/ADMA axis

作者: Nicholas S. Kirkby , Abel Tesfai , Blerina Ahmetaj‐Shala , Hime H. Gashaw , Walkyria Sampaio

DOI: 10.1096/FJ.201600647R

关键词:

摘要: Nonsteroidal antiinflammatory drugs, including ibuprofen, are among the most commonly used medications and produce their effects by blocking cyclooxygenase (COX)-2. Their use is associated with increased risk of heart attacks caused COX-2 in vasculature and/or kidney, our recent work implicating endogenous NOS inhibitor asymmetric dimethylarginine (ADMA), a cardiotoxic hormone whose can be prevented l-arginine. The ibuprofen salt arginate (Spididol) was created to increase solubility but we suggest that it could also augment NO pathway through codelivery arginine. Here investigated idea act simultaneously inhibit preserve pathway. Ibuprofen functioned similarly sodium for inhibition mouse/human COX-2, only served as substrate NOS. not reversed inhibitory ADMA NG-nitro-l-arginine methyl ester on inducible (macrophages) endothelial vitro (aorta) vivo (blood pressure). These observations show provides, one preparation, negate harmful cardiovascular consequences mediated renal ADMA. While remarkably simple, findings potentially game-changing nonsteroidal drug arena.-Kirkby, N. S., Tesfai, A., Ahmetaj-Shala, B., Gashaw, H. H., Sampaio, W., Etelvino, G., Leao, M., Santos, R. Mitchell, J. A. retains eNOS activity reverses dysfunction: implications COX-2/ADMA axis.

参考文章(42)
G Geisslinger, H Bezler, B Nuernberg, K Brune, K Dietzel, Therapeutically relevant differences in the pharmacokinetical and pharmaceutical behavior of ibuprofen lysinate as compared to ibuprofen acid. International journal of clinical pharmacology, therapy, and toxicology. ,vol. 27, pp. 324- 328 ,(1989)
Naseh Pahlavani, Mostafa Jafari, Masoud Rezaei, Hamid Rasad, Omid Sadeghi, Hossein Ali Rahdar, Mohammad Hasan Entezari, L-arginine supplementation and risk factors of cardiovascular diseases in healthy men: a double-blind randomized clinical trial. F1000Research. ,vol. 3, pp. 306- 306 ,(2014) , 10.12688/F1000RESEARCH.5877.1
Jane A. Mitchell, Markus Hecker, Erik E. Ånggård, John R. Vane, Cultured endothelial cells maintain their L-arginine level despite the continuous release of EDRF. European Journal of Pharmacology. ,vol. 182, pp. 573- 576 ,(1990) , 10.1016/0014-2999(90)90058-E
Jane A. Mitchell, Timothy D. Warner, COX isoforms in the cardiovascular system: understanding the activities of non-steroidal anti-inflammatory drugs. Nature Reviews Drug Discovery. ,vol. 5, pp. 75- 86 ,(2006) , 10.1038/NRD1929
Andrzej Surdacki, Jens Martens-Lobenhoffer, Alicja Wloch, Ewa Marewicz, Tomasz Rakowski, Ewa Wieczorek-Surdacka, Jacek S. Dubiel, Juliusz Pryjma, Stefanie M. Bode-Böger, Elevated plasma asymmetric dimethyl-l-arginine levels are linked to endothelial progenitor cell depletion and carotid atherosclerosis in rheumatoid arthritis Arthritis & Rheumatism. ,vol. 56, pp. 809- 819 ,(2007) , 10.1002/ART.22424
Richard M.J. Palmer, Daryl D. Rees, David S. Ashton, Salvador Moncada, L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation Biochemical and Biophysical Research Communications. ,vol. 153, pp. 1251- 1256 ,(1988) , 10.1016/S0006-291X(88)81362-7
W. C. Sessa, M. Hecker, J. A. Mitchell, J. R. Vane, The metabolism of L-arginine and its significance for the biosynthesis of endothelium-derived relaxing factor: L-glutamine inhibits the generation of L-arginine by cultured endothelial cells. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 87, pp. 8607- 8611 ,(1990) , 10.1073/PNAS.87.21.8607
Yan Cheng, Miao Wang, Ying Yu, John Lawson, Colin D Funk, Garret A FitzGerald, Cyclooxygenases, microsomal prostaglandin E synthase-1, and cardiovascular function Journal of Clinical Investigation. ,vol. 116, pp. 1391- 1399 ,(2006) , 10.1172/JCI27540
J. A. Mitchell, P. Akarasereenont, C. Thiemermann, R. J. Flower, J. R. Vane, Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase Proceedings of the National Academy of Sciences of the United States of America. ,vol. 90, pp. 11693- 11697 ,(1993) , 10.1073/PNAS.90.24.11693